Vglyza M 50mg/500mg Tablet 10's

• Vglyza M 50mg/500mg Tablet is a combination of Vildagliptin 50mg and Metformin 500mg that control high blood sugar levels in people with type 2 diabetes mellitus
• Addictive Drug: No
• Therapeutic Class: Anti Diabetic
• Schedule “H” prescription drug Caution: Not to be sold without the prescription of a registered medical practitioner
• Schedule “G” prescription drug Caution: This medication must be taken only under medical supervision
• Store in a dry, cool place below 30°C away from light and moisture
• This prescription drug has a minimum of 6 months expiry after dispatch
• Keep out of the reach of children

Treatment of Type 2 diabetes mellitus

• Medication is not suited for an alcoholic person as it is unsafe to take Vglyza M 50/500mg Tablet after consumption of alcohol
• Do not take a double dose of Vglyza M 50/500mg Tablet if you miss a dosage skip the dose and follow the regular schedule prescribed by your doctor

Pregnant and breastfeeding women must consult their doctors as Vglyza M 50/500mg Tablet may be unsafe to use during pregnancy

• Take the tablet in addition to regular exercise and a healthy diet to lower levels of blood sugar
• Take the tablet with food to lower your chance of having an upset stomach
• Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines
• Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic
• Inform your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting, and stomach pain as Vglyza M 50mg/500mg Tablet may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood
• Your doctor may check your kidney and liver function before starting treatment and regularly thereafter. Inform your doctor if you develop symptoms such as abdominal pain, fatigue, loss of appetite, darkened urine, or yellowing of the eyes or skin (jaundice)

• Nausea and vomiting
• Diarrhea or Stomach pain
• Loss of appetite and Dizziness
• Headache
• Trembling
• Metallic taste
• Hypoglycemia or low blood sugar level

Vglyza M 50mg/500mg Tablet can be taken with food to avoid stomach upset as prescribed by your doctor. Swallow it as a whole, do not chew or crush or break the tablet

Vglyza M 50mg/500mg Tablet is composed of two antidiabetic medicines Metformin and Vildagliptin

Metformin lowers glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to insulin

Vildagliptin is a DPP-4 inhibitor that increases the release of insulin from the pancreas and decreases the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels

Q. Can the use of Vglyza M 50/500mg Tablet cause nausea and vomiting?
Yes, the use of Vglyza M 50/500mg Tablet can cause nausea and vomiting. In case of vomiting, drink plenty of water or other fluids

Q. What is Vglyza M 50/500mg Tablet?
Vglyza M 50/500mg Tablet is a combination of Metformin and Vildagliptin used for the treatment of Type 2 diabetes mellitus patients above 18 years of age

Q. Can the use of Vglyza M 50/500mg Tablet cause lactic acidosis?
Yes, the use of Vglyza M 50/500mg Tablet can lead to lactic acidosis. It is a medical emergency that is caused by increased levels of lactic acid in the blood. It is also known as MALA (Metformin-associated lactic acidosis). It is a very rare side effect associated with the use of metformin

Q. Can the use of Vglyza M 50mg/500mg Tablet lead to Vitamin B12 deficiency?
Yes, the use of Metformin can cause Vitamin B12 deficiency with long-term use. It interferes with the absorption of Vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems

• Metformin is a biguanide that lowers the glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin
• Vildagliptin inhibits the enzyme DPP4 inhibitor and increases the release of insulin from the pancreas
• The use of this medicine is also considered to be harmful to patients with severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis, diabetic ketoacidosis
• Patients with kidney or liver disease or problems in their pancreas must consult their doctor before use of this medication